ADUS — what changed in the latest 10-Q
A section-by-section comparison of ADUS's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-04 vs the prior 10-Q · 2026-05-05
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +15 | −6 | ~44 | 42 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +1 | −6 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-04
On May 1, 2026, the Company completed its acquisition of HomeCourt Home Care (the “HomeCourt Acquisition”), for approximately $12.2 million, with funding provided by available cash. With the HomeCourt Acquisition, the Company expanded its services within its personal care segment to Indiana and reco…
Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale was occurring over time. In connection with this transaction, the …
CMS has increased program integrity efforts within the Medicare and Medicaid programs, including by withholding or deferring federal Medicaid funding in states that federal administrators determine do not have sufficient anti-fraud systems, which may delay or otherwise affect the reimbursement provi…
Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
The following table sets forth our unaudited condensed consolidated results of operations.
Text removed vs the prior filing · source: 10-Q · 2026-05-05
Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coord…
Net service revenues from state, local, and other governmental programs accounted for 49.7% and 51.5% of net service revenues for the three months ended March 31, 2026 and 2025, respectively. Managed care organizations accounted for 47.6% and 45.3% of net service revenues for the three months ended …
Gross profit, expressed as a percentage of net service revenues, was 27.7% for the three months ended March 31, 2026, compared to 27.6% for the three months ended March 31, 2025.
Revenue per patient day is hospice revenue divided by the number of patient days in the period.
Net service revenues decreased by $1.3 million for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to lower volumes, including lower recertifications and visits, and the continued impact of efforts to manage payor mix within our home health ope…
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-04
Not applicable. Without limiting the generality of the foregoing, during the quarter ended June 30, 2026, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.
Text removed vs the prior filing · source: 10-Q · 2026-05-05
During the quarter ended March 31, 2026, each of the following directors and Section 16 officers adopted a Rule 10b5-1 Trading Arrangement (as defined in Item 408(a) of Regulation S-K) to sell common shares:
EVP and Chief Government Affairs & Community Relations Officer
David Tucker EVP and Chief Strategy Officer March 5, 2026 February 23, 2027 4,277 n/a
(1) Each plan will expire on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement.
(2) This column indicates the total number of shares vesting in connection with equity awards, not the number of shares to be sold. The actual number of shares to be sold will be a smaller number based on whatever is required to satisfy payment of applicable withholding taxes under sell-to-cover arr…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice